"Intrahepatic cholangiocarcinoma" trang 1 - tải miễn phí từ tailieunhanh
Proteomic analysis identifies deregulated metabolic and oxidative-associated proteins in Italian intrahepatic cholangiocarcinoma patients

Proteomic analysis identifies deregulated metabolic and oxidative-associated proteins in Italian intrahepatic cholangiocarcinoma patients
11    49    1
Optimization of a laparoscopic procedure for advanced intrahepatic cholangiocarcinoma based on the concept of “waiting time”: A preliminary report

Optimization of a laparoscopic procedure for advanced intrahepatic cholangiocarcinoma based on the concept of “waiting time”: A preliminary report
14    12    1
Distinct clinical and prognostic implication of IDH1/2 mutation and other most frequent mutations in large duct and small duct subtypes of intrahepatic cholangiocarcinoma

Distinct clinical and prognostic implication of IDH1/2 mutation and other most frequent mutations in large duct and small duct subtypes of intrahepatic cholangiocarcinoma
12    74    0
Perineural invasion as a prognostic factor for intrahepatic cholangiocarcinoma after curative resection and a potential indication for postoperative chemotherapy: A retrospective cohort study

Perineural invasion as a prognostic factor for intrahepatic cholangiocarcinoma after curative resection and a potential indication for postoperative chemotherapy: A retrospective cohort study
11    73    0
Failure patterns after curative resection for intrahepatic cholangiocarcinoma: Possible implications for postoperative radiotherapy

Failure patterns after curative resection for intrahepatic cholangiocarcinoma: Possible implications for postoperative radiotherapy
11    58    0
Opisthorchiasis with proinflammatory cytokines (IL-1β and TNF-α) polymorphisms influence risk of intrahepatic cholangiocarcinoma in Thailand: A nested case-control study

Opisthorchiasis with proinflammatory cytokines (IL-1β and TNF-α) polymorphisms influence risk of intrahepatic cholangiocarcinoma in Thailand: A nested case-control study
7    78    0
Stereotactic body radiotherapy (SBRT) for locally advanced intrahepatic and extrahepatic cholangiocarcinoma

Stereotactic body radiotherapy (SBRT) for locally advanced intrahepatic and extrahepatic cholangiocarcinoma
8    60    1
Perioperative blood transfusion does not affect recurrence-free and overall survivals after curative resection for intrahepatic cholangiocarcinoma: A propensity score matching analysis

Perioperative blood transfusion does not affect recurrence-free and overall survivals after curative resection for intrahepatic cholangiocarcinoma: A propensity score matching analysis
11    58    1
Risk stratification system to predict recurrence of intrahepatic cholangiocarcinoma after hepatic resection

Risk stratification system to predict recurrence of intrahepatic cholangiocarcinoma after hepatic resection
9    76    1
CUL4A overexpression as an independent adverse prognosticator in intrahepatic cholangiocarcinoma

CUL4A overexpression as an independent adverse prognosticator in intrahepatic cholangiocarcinoma
10    34    1
Tumor-associated lymphangiogenesis predicts unfavorable prognosis of intrahepatic cholangiocarcinoma

Tumor-associated lymphangiogenesis predicts unfavorable prognosis of intrahepatic cholangiocarcinoma
10    28    1
High Beclin-1 and ARID1A expression corelates with poor survival and high recurrence in intrahepatic cholangiocarcinoma: A histopathological retrospective study

High Beclin-1 and ARID1A expression corelates with poor survival and high recurrence in intrahepatic cholangiocarcinoma: A histopathological retrospective study
11    22    1
Impact of liver fibrosis score on prognosis after common therapies for intrahepatic cholangiocarcinoma: A propensity score matching analysis

Impact of liver fibrosis score on prognosis after common therapies for intrahepatic cholangiocarcinoma: A propensity score matching analysis
11    62    1
Establishment of a patient-derived intrahepatic cholangiocarcinoma xenograft model with KRAS mutation

Establishment of a patient-derived intrahepatic cholangiocarcinoma xenograft model with KRAS mutation
11    49    1
Clinical and pathological significance of ROS1 expression in intrahepatic cholangiocarcinoma

Clinical and pathological significance of ROS1 expression in intrahepatic cholangiocarcinoma
9    78    1
Cholelithiasis and the risk of intrahepatic cholangiocarcinoma: A meta-analysis of observational studies

Cholelithiasis and the risk of intrahepatic cholangiocarcinoma: A meta-analysis of observational studies
7    74    1
Identification of a novel microRNA signature associated with intrahepatic cholangiocarcinoma (ICC) patient prognosis

Identification of a novel microRNA signature associated with intrahepatic cholangiocarcinoma (ICC) patient prognosis
8    28    1
High platelet-to-lymphocyte ratio is associated with poor prognosis in patients with unresectable intrahepatic cholangiocarcinoma receiving gemcitabine plus cisplatin

High platelet-to-lymphocyte ratio is associated with poor prognosis in patients with unresectable intrahepatic cholangiocarcinoma receiving gemcitabine plus cisplatin
13    30    1
The roles of Notch1 expression in the migration of intrahepatic cholangiocarcinoma

The roles of Notch1 expression in the migration of intrahepatic cholangiocarcinoma
10    28    1
LncRNA MT1JP plays a protective role in intrahepatic cholangiocarcinoma by regulating miR-18a-5p/FBP1 axis

LncRNA MT1JP plays a protective role in intrahepatic cholangiocarcinoma by regulating miR-18a-5p/FBP1 axis
14    35    1